Clearance Summary
Annalise Enterprise CXR Triage Trauma received FDA 510(k) clearance under submission number K222179, sponsored by Annalise-Ai Pty , Ltd.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Radiology review panel. The statutory decision date of record is 2023-03-28.
- Submission: K222179
- Applicant / Sponsor: Annalise-Ai Pty , Ltd.
- Clearance pathway: Traditional
- Review panel: Radiology
- Device class: Class II
- Regulation citation: 21 CFR 892.2080
- Decision date: 2023-03-28
Classification & Regulation
This clearance is catalogued under FDA product code QFM and 21 CFR 892.2080, within the Radiology review panel as a Class II device.